Metropolitan Life Insurance Company (MetLife)’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,541
Closed -$499K 2644
2021
Q4
$499K Buy
5,541
+425
+8% +$38.3K 0.01% 1433
2021
Q3
$473K Sell
5,116
-168
-3% -$15.5K 0.01% 1504
2021
Q2
$411K Sell
5,284
-190
-3% -$14.8K 0.01% 1648
2021
Q1
$408K Sell
5,474
-246
-4% -$18.3K 0.01% 1539
2020
Q4
$975K Sell
5,720
-44
-0.8% -$7.5K 0.01% 896
2020
Q3
$809K Sell
5,764
-149
-3% -$20.9K 0.01% 870
2020
Q2
$948K Buy
5,913
+966
+20% +$155K 0.02% 769
2020
Q1
$484K Sell
4,947
-156
-3% -$15.3K 0.01% 1064
2019
Q4
$658K Sell
5,103
-95
-2% -$12.3K 0.01% 1164
2019
Q3
$392K Buy
5,198
+308
+6% +$23.2K 0.01% 1444
2019
Q2
$743K Sell
4,890
-113
-2% -$17.2K 0.01% 1068
2019
Q1
$596K Sell
5,003
-104
-2% -$12.4K 0.01% 1182
2018
Q4
$557K Buy
5,107
+261
+5% +$28.5K 0.01% 1127
2018
Q3
$783K Sell
4,846
-28
-0.6% -$4.52K 0.01% 1066
2018
Q2
$644K Sell
4,874
-14,323
-75% -$1.89M 0.01% 1151
2018
Q1
$1.42M Buy
19,197
+333
+2% +$24.7K 0.02% 729
2017
Q4
$1.05M Sell
18,864
-20,529
-52% -$1.14M 0.01% 867
2017
Q3
$1.79M Buy
39,393
+3,900
+11% +$177K 0.01% 975
2017
Q2
$1.2M Hold
35,493
0.01% 1144
2017
Q1
$1.05M Hold
35,493
0.01% 1211
2016
Q4
$974K Buy
35,493
+3,717
+12% +$102K 0.01% 1306
2016
Q3
$1.95M Hold
31,776
0.01% 964
2016
Q2
$606K Hold
31,776
﹤0.01% 1565
2016
Q1
$620K Hold
31,776
﹤0.01% 1459
2015
Q4
$1.23M Buy
31,776
+2,842
+10% +$110K 0.01% 1084
2015
Q3
$929K Sell
28,934
-802
-3% -$25.8K 0.01% 1225
2015
Q2
$905K Sell
29,736
-1,913
-6% -$58.2K 0.01% 1356
2015
Q1
$420K Hold
31,649
﹤0.01% 1647
2014
Q4
$458K Hold
31,649
﹤0.01% 1818
2014
Q3
$668K Hold
31,649
﹤0.01% 1527
2014
Q2
$943K Buy
31,649
+620
+2% +$18.5K 0.01% 1395
2014
Q1
$746K Buy
31,029
+970
+3% +$23.3K 0.01% 1544
2013
Q4
$612K Buy
30,059
+2,815
+10% +$57.3K ﹤0.01% 1665
2013
Q3
$1.29M Hold
27,244
0.01% 1145
2013
Q2
$1.04M Buy
+27,244
New +$1.04M 0.01% 1213